Positron Corporation (POSC)
Positron Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in North Tonawanda, NY, US. The stock last traded at $1.75, up 9.38% on the session, giving a market capitalisation of $57.5M. On trailing twelve-month figures it carries a trailing P/E of -5.43, a net margin of -1996.3%. Its beta of 0.14 implies it has historically moved less than the broad market.
Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency. Positron Corporation was founded in 1983 and operates from its headquarters in Niagara Falls, New York.
Positron Corporation is most often compared with the following Healthcare names: